Incidence of biopsy confirmed acute rejection at 12 months. 12 months [clinicaltrials_resource:295b0d1711a37afcb06c2c175e48666f]
All the patients who enroll in this study will receive the same medications (tacrolimus, mycophenolate mofetil, and a short coarse of steroids) to prevent rejection of the liver transplant. All participants will be gradually taken off prednisone if they are 90 days or longer post liver transplant and have not had a rejection in the last 30 days.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Incidence of biopsy confirmed acute rejection at 12 months. 12 months [clinicaltrials_resource:295b0d1711a37afcb06c2c175e48666f]
All the patients who enroll in this study will receive the same medications (tacrolimus, mycophenolate mofetil, and a short coarse of steroids) to prevent rejection of the liver transplant. All participants will be gradually taken off prednisone if they are 90 days or longer post liver transplant and have not had a rejection in the last 30 days.
Bio2RDF identifier
295b0d1711a37afcb06c2c175e48666f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:295b0d1711a37afcb06c2c175e48666f
measure [clinicaltrials_vocabulary:measure]
Incidence of biopsy confirmed acute rejection at 12 months.
time frame [clinicaltrials_vocabulary:time-frame]
description
All the patients who enroll in ...... rejection in the last 30 days.
identifier
clinicaltrials_resource:295b0d1711a37afcb06c2c175e48666f
title
Incidence of biopsy confirmed acute rejection at 12 months. 12 months
@en
type
label
Incidence of biopsy confirmed ...... b0d1711a37afcb06c2c175e48666f]
@en